- Home
- INM vs SIGIP Comparison
INM vs SIGIP Comparison
Compare INM & SIGIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- SIGIP
- Stock Information
- Founded
- INM 1981
- SIGIP N/A
- Country
- INM Canada
- SIGIP United States
- Employees
- INM N/A
- SIGIP 2800
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- SIGIP Property-Casualty Insurers
- Sector
- INM Health Care
- SIGIP Finance
- Exchange
- INM Nasdaq
- SIGIP Nasdaq
- Market Cap
- INM 5.0M
- SIGIP N/A
- IPO Year
- INM N/A
- SIGIP N/A
- Fundamental
- Price
- INM $2.07
- SIGIP $17.91
- Analyst Decision
- INM
- SIGIP
- Analyst Count
- INM 0
- SIGIP 0
- Target Price
- INM N/A
- SIGIP N/A
- AVG Volume (30 Days)
- INM 116.2K
- SIGIP N/A
- Earning Date
- INM 11-13-2025
- SIGIP N/A
- Dividend Yield
- INM N/A
- SIGIP N/A
- EPS Growth
- INM N/A
- SIGIP N/A
- EPS
- INM N/A
- SIGIP N/A
- Revenue
- INM $4,942,633.00
- SIGIP N/A
- Revenue This Year
- INM N/A
- SIGIP N/A
- Revenue Next Year
- INM N/A
- SIGIP N/A
- P/E Ratio
- INM N/A
- SIGIP N/A
- Revenue Growth
- INM 7.50
- SIGIP N/A
- 52 Week Low
- INM $1.72
- SIGIP N/A
- 52 Week High
- INM $8.27
- SIGIP N/A
- Technical
- Relative Strength Index (RSI)
- INM 42.37
- SIGIP 47.32
- Support Level
- INM $2.04
- SIGIP $17.69
- Resistance Level
- INM $2.26
- SIGIP $18.04
- Average True Range (ATR)
- INM 0.14
- SIGIP 0.20
- MACD
- INM -0.01
- SIGIP -0.03
- Stochastic Oscillator
- INM 10.44
- SIGIP 31.70
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
About SIGIP Selective Insurance Group Inc. Depositary Shares each representing a 1/1000th interest in a share of 4.60% Non-Cumulative Preferred Stock Series B
Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, Investments. Majority of revenue is gained from Standard Personal Lines. Currently company has it's revenues from States of USA and Columbia.